Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-09

Clinical Trial Update: New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules

View source ↗

Summary

This clinical trial is evaluating new diagnostic criteria for assessing response to ablation therapy in hepatocellular carcinoma nodules.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Hepatocellular Carcinoma | Status: NOT_YET_RECRUITING